J&J Invests In Consumer Business For Long Haul, Not Quick Sale
This article was originally published in The Pink Sheet
Executive Summary
"We believe the consumer business at J&J is an absolute integral part of our company," says CEO Alex Gorsky.
You may also be interested in...
Sanofi Consumer 'Very Complementary' To Pharma, Fits In Firm's 'Right Structure'
Sanofi wants to keep all its current businesses under the same roof, including consumer health, says CEO Olivier Brandicourt. "We think we have now the right structure," Brandicourt responds to question on whether Sanofi would follow other large pharmas in positioning consumer health or other divisions for separation.
J&J Consumer Products Business Steers Toward Acquisitions For Growth
Sales of Tylenol, Motrin and other analgesics increased more than 13% during the firm's latest quarter as total US OTC sales reached $389m. Sales of the Listerine line grew 7% to drive domestic oral care product sales up 8.2% to $159m.
J&J/McNeil Completes Remediation Under Consent Decree
FDA officials on Aug. 21 notified the firm that its Fort Washington, Pa., manufacturing plant is compliant with the agency’s GMP regulations for drugs.